Intelligent Bio Solutions (INBS) Equity Average (2020 - 2025)

Intelligent Bio Solutions' Equity Average history runs 6 years deep, the most recent figure standing at $4.0 million for Q2 2025.

• In Q2 2025, Equity Average fell 58.61% year-over-year to $4.0 million; the TTM figure through Jun 2025 stood at $4.0 million (down 58.61% YoY), while the FY2025 annual figure was $5.6 million, down 5.82% from the prior year.
• Equity Average was $4.0 million for Q2 2025 at Intelligent Bio Solutions, down from $4.6 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $17.3 million in Q1 2021 to a low of $2.2 million in Q4 2023.
• Historically, Equity Average has averaged $8.0 million across 5 years, with a median of $7.4 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Equity Average soared 445.03% in 2021, then slumped 71.6% in 2023.
• A 5-year view of Equity Average shows it stood at $11.8 million in 2021, then plunged by 34.35% to $7.7 million in 2022, then plunged by 71.6% to $2.2 million in 2023, then soared by 131.23% to $5.1 million in 2024, then dropped by 21.79% to $4.0 million in 2025.
• The last three Equity Average figures came in at $4.0 million (Q2 2025), $4.6 million (Q1 2025), and $5.1 million (Q4 2024), per Business Quant data.